stockrow
Friday 6 November 2026
Export FMS’s income statement to Excel — free account
Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024.
- Revenue
- −0.49%
- EPS
- −10.6%
- Free cash flow
- −3.47%
- Total debt
- +8.09%
Quarter to September 2026, against a year earlier
23.32
0.34
−1.44%
Follow FMS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 7 | 8 |
+8 more TTM periods Free account |
| 5.90% | 6.77% | 6.58% | 6.66% | ||
| 2.62% | 3.01% | 3.04% | 3.10% | ||
ROIC |
5.47% | 5.78% | 5.45% | 5.84% | |
Return on Tangible Assets |
23.68% | 22.99% | 18.98% | 19.04% | |
Average Days of Receivables |
64.00 | 64.86 | 70.66 | 59.04 | |
Free Cash Flow per Share |
3.86 | 3.82 | 3.71 | 3.46 | |
Free Cash Flow |
2,029.79 | 2,052.84 | 2,041.59 | 2,016.52 | |
Capital Expenditures |
(1,209.88) | (1,179.97) | (1,085.71) | (1,016.76) | |
| Other line items | |||||
Cash ROIC |
7.74% | 7.83% | 7.47% | 7.54% | |
Accounts Receivable Turnover |
5.81 | 5.89 | 5.52 | 6.10 | |
Accounts Payable Turnover |
16.38 | 17.68 | 16.76 | 16.43 | |
Inventory Turnover |
6.39 | 6.71 | 6.81 | 7.09 | |
Average Days of Payables |
23.39 | 22.66 | 22.86 | 20.89 | |
Days of Inventory on Hand |
60.85 | 59.23 | 59.13 | 53.52 | |
Tax Rate |
(0.23) | (0.21) | (0.21) | (0.21) | |
Research and Development Expense of Revenue |
0.81% | 0.80% | 0.79% | 0.80% | |
Selling, General and Administrative Expense of Revenue |
15.48% | 15.32% | 15.66% | 15.45% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
4.43 | 4.72 | 4.63 | 4.75 | |
Operating CF/Net income |
3.42 | 2.98 | 2.88 | 2.74 | |
Depreciation/Fixed assets |
0.45 | 0.43 | 0.44 | 0.43 | |
Capex/Depreciation |
(0.66) | (0.66) | (0.60) | (0.60) | |
Revenue per Share |
43.06 | 42.23 | 40.80 | 38.13 | |
Operating CF per Share |
6.16 | 6.02 | 5.68 | 5.21 | |
Capex per Share |
(2.30) | (2.20) | (1.97) | (1.75) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 |
Columns are period end dates · fundamentals updated 5 Nov 2026